Annual Accounts Receivable
$14.87 M
+$8.64 M+138.87%
December 31, 2023
Summary
- As of February 8, 2025, RYTM annual accounts receivable is $14.87 million, with the most recent change of +$8.64 million (+138.87%) on December 31, 2023.
- During the last 3 years, RYTM annual accounts receivable has risen by +$14.87 million (+100.00%).
- RYTM annual accounts receivable is now at all-time high.
Performance
RYTM Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$19.31 M
+$1.71 M+9.71%
September 30, 2024
Summary
- As of February 8, 2025, RYTM quarterly accounts receivable is $19.31 million, with the most recent change of +$1.71 million (+9.71%) on September 30, 2024.
- Over the past year, RYTM quarterly accounts receivable has increased by +$4.61 million (+31.38%).
- RYTM quarterly accounts receivable is now at all-time high.
Performance
RYTM Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
RYTM Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +138.9% | +31.4% |
| 3 y3 years | +100.0% | +1783.5% |
| 5 y5 years | - | +1783.5% |
RYTM Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1350.4% | at high | +2139.7% |
| 5 y | 5-year | at high | -100.0% | at high | -100.0% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Rhythm Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $19.31 M(+9.7%) |
| Jun 2024 | - | $17.60 M(+19.8%) |
| Mar 2024 | - | $14.70 M(-1.2%) |
| Dec 2023 | $14.87 M | $14.87 M(+2.2%) |
| Sep 2023 | - | $14.54 M(+5.1%) |
| Jun 2023 | - | $13.83 M(+70.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $8.12 M(+30.4%) |
| Dec 2022 | $6.22 M(+507.2%) | $6.22 M(+87.0%) |
| Sep 2022 | - | $3.33 M(+95.0%) |
| Jun 2022 | - | $1.71 M(+98.0%) |
| Mar 2022 | - | $862.00 K(-15.9%) |
| Dec 2021 | $1.02 M(>+9900.0%) | $1.02 M(>+9900.0%) |
| Dec 2020 | $0.00 | $0.00 |
FAQ
- What is Rhythm Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals annual accounts receivable year-on-year change?
- What is Rhythm Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Rhythm Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of RYTM is $14.87 M
What is the all time high annual accounts receivable for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high annual accounts receivable is $14.87 M
What is Rhythm Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, RYTM annual accounts receivable has changed by +$8.64 M (+138.87%)
What is Rhythm Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of RYTM is $19.31 M
What is the all time high quarterly accounts receivable for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high quarterly accounts receivable is $19.31 M
What is Rhythm Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, RYTM quarterly accounts receivable has changed by +$4.61 M (+31.38%)